GlassScriptPhysician profile
Laura H Becker
NPI 1417403494
$1,217.14
in general payments reported to CMS, 2019-2025
16 companies · $831 in 2025
The $831 reported for 2025 was more than what 84% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $16.12 · 2023: $93.36 · 2024: $277 · 2025: $831.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,066 · Education: $135.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,066.02 |
| Education | $135.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $306.00 | 2021-2025 | |
| Viiv Healthcare Company | $266.62 | 2025 | Dovato, Cabenuva, Apretude |
| Janssen Biotech, INC. | $135.00 | 2024-2025 | Tremfya |
| Gilead Sciences, INC. | $81.22 | 2025 | Biktarvy |
| Ucb, INC. | $62.58 | 2024-2025 | Bimzelx |
| Aurinia Pharma U.S., INC. | $56.36 | 2023-2024 | Lupkynis |
| Paratek Pharmaceuticals, INC. | $53.85 | 2025 | Nuzyra |
| Novartis Pharmaceuticals Corporation | $52.84 | 2024-2025 | |
| E.R. Squibb & Sons, L.L.C. | $39.60 | 2025 | Orencia |
| Glaxosmithkline, LLC. | $27.70 | 2025 | Benlysta |
| Astrazeneca Pharmaceuticals LP | $25.79 | 2025 | Saphnelo |
| Amgen INC. | $24.56 | 2024 | Otezla, Enbrel |
| Kiniksa Pharmaceuticals International, Plc | $24.17 | 2024 | Arcalyst |
| Pfizer INC. | $21.26 | 2024 | |
| Insmed, INC. | $20.03 | 2025 | Brinsupri, Arikayce |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $19.56 | 2025 | Pifeltro, Capvaxive |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laura Becker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.